Mannitol Versus Supportive Care in Ciguatera Fish Poisoning
Primary Purpose
Ciguatoxin
Status
Unknown status
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Mannitol
Sponsored by
About this trial
This is an interventional treatment trial for Ciguatoxin focused on measuring mannitol, treatment
Eligibility Criteria
Inclusion Criteria:
- History consistent with ciguatera poisoning
Exclusion Criteria:
- Minors
- pregnant patients
- those unable to give consent
- severe congestive heart failure or renal failure
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Control
Investigational
Arm Description
Patients will receive supportive care measures.
Patients will receive 500mL of 20% mannitol
Outcomes
Primary Outcome Measures
Symptom score
Covers a variety of neurological and gastrointestinal symptoms on a 0-4 score
Secondary Outcome Measures
Full Information
NCT ID
NCT02570971
First Posted
October 6, 2015
Last Updated
October 6, 2015
Sponsor
University of South Florida
Collaborators
Florida Poison Control Center
1. Study Identification
Unique Protocol Identification Number
NCT02570971
Brief Title
Mannitol Versus Supportive Care in Ciguatera Fish Poisoning
Official Title
Mannitol Versus Supportive Care in Ciguatera Fish Poisoning: A Randomized Control Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2015
Overall Recruitment Status
Unknown status
Study Start Date
October 2015 (undefined)
Primary Completion Date
June 2018 (Anticipated)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of South Florida
Collaborators
Florida Poison Control Center
4. Oversight
5. Study Description
Brief Summary
Ciguatera poisoning, caused by the ingestion of ciguatoxin-containing fish, is a global public health concern. In the US, the vast majority of ciguatera poisonings occur in Florida, followed by Hawaii and California. Equipoise exists in the medical literature regarding the effectiveness of mannitol therapy in treatment of ciguatera poisoning. While there are many case reports attesting to its utility, the only randomized control trial (RCT) comparing mannitol therapy with supportive care failed to show any significant benefit from mannitol treatment for a variety of clinical outcomes. Investigators therefore propose a second, larger RCT to test this question.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ciguatoxin
Keywords
mannitol, treatment
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Control
Arm Type
No Intervention
Arm Description
Patients will receive supportive care measures.
Arm Title
Investigational
Arm Type
Experimental
Arm Description
Patients will receive 500mL of 20% mannitol
Intervention Type
Drug
Intervention Name(s)
Mannitol
Primary Outcome Measure Information:
Title
Symptom score
Description
Covers a variety of neurological and gastrointestinal symptoms on a 0-4 score
Time Frame
24 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
History consistent with ciguatera poisoning
Exclusion Criteria:
Minors
pregnant patients
those unable to give consent
severe congestive heart failure or renal failure
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michael Butterfield, MD MS MPH
Email
mbutterfield@health.usf.edu
12. IPD Sharing Statement
Learn more about this trial
Mannitol Versus Supportive Care in Ciguatera Fish Poisoning
We'll reach out to this number within 24 hrs